Univest
Univest
  • Markets

Atul Gears Up for Q3 Reveal on 23rd January; Check Key Expectations Here

  • January 22, 2026
  • Posted by: sachet
  • Category: News
No Comments
Atul Gears Up for Q3 Results Expectations

Click and Sign Up to Get Live Updates on Q3 Results 

Atul’s Q3 results FY26 are scheduled to be announced on 23rd January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Table of Contents

Toggle
  • Atul Q3 Results 2026 Preview
  • Atul Share Performance 
  • Key Factors to Watch for Atul Q3 Results FY26 
  • Final Thoughts
  • Recent Articles

Atul Q3 Results 2026 Preview

  • Atul’s revenue is expected to be in the range of ₹1,416.83 crore, a 1.72% YoY increase. 
  • Profit After Tax, or PAT, is projected to fall by 20.52% YoY. 
  • Atul’s EBITDA is expected to fall to ₹143.07 crore. 
  • Net profit is ₹108.74 crore, down 20.52% YoY 

Atul Share Performance 

  • Over the past six months, Atul’s share price has fallen by 14.04% to ₹5,821.50.
  • Moreover, over the past year, the stock has decreased by 14.14%.
  • Despite this weak short-term performance, Atul’s stock has delivered a financially sound 10.57% return over the past 5 years.
  • As of 22nd January 2026, the stock traded at ₹5,821.50 per share.

Key Factors to Watch for Atul Q3 Results FY26 

  • Revenue & Volume Growth: Demand trends across life science and performance chemicals, export performance, and volume recovery.
  • Margins & Cost Pressures: Impact of raw material prices, operating leverage, and product mix on EBITDA and PAT margins.
  • Speciality vs Commodity Mix: Contribution from higher-margin speciality chemicals and traction in value-added products.
  • Management Commentary & Outlook: Guidance on demand recovery, capacity utilisation, capex plans, and global market conditions.

Final Thoughts

Atul will announce its Q3 FY26 results on 23rd January 2026. Analysts expect 1.72% YoY revenue growth, a 20.52% fall in PAT, and a 13.41% fall in EBITDA. Atul focuses on expanding its speciality and life science chemicals portfolio, improving margins through a better product mix, strengthening exports, and driving growth via capacity expansion and innovation.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Top 10 Penny Stocks in India | Penny Stocks to Buy in 2026

Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

Dev Accelerator IPO GMP & Review: Apply or Avoid?

Vigor Plast India IPO Listing Preview: What to Expect Now?

Krupalu Metals IPO GMP: Day 3 IPO Live Updates



Q3 Results Q3 Results 2026

Leave a Reply Cancel reply